Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Henry Schein To Showcase New Dental Offerings At GNYDM

Published 11/24/2019, 09:04 PM
Updated 07/09/2023, 06:31 AM

Henry Schein, Inc. (NASDAQ:HSIC) announced that it will be exhibiting the new lineup of products and educational offerings at the 2019 Greater New York Dental Meeting (GNYDM), which is slated to start on Nov 29. The company’s suite of solutions, education, and social media activities, featuring pioneers in the dental industry, should enable oral healthcare professionals to explore new options revolutionizing digital dentistry.

The portfolio of digital equipment and technology solutions set to be displayed at the GNYDM includes its practice management, marketing, and patient engagement software solutions from Henry Schein One; a wide array of financial, business, and office design services and solutions from Henry Schein Financial Services, and Henry Schein ProRepair. The company will also be hosting a live event to demonstrate the optimization of Dentrix treatment plans and other workflow solutions designed to enhance productivity.

Products to be Demonstrated

At the meeting, Henry Schein will demonstrate the latest products and technology solutions such as 3Shape TRIOS Move, 3Shape TRIOS 3 Basic, the A-dec 500 chair, Convergent Dental Solea Dental Laser, and Dentsply Sirona CEREC Primescan. Henry Schein’s Exclusive Product Specialists will be presenting the new Clinician’s Choice Bluewave Laser, Reveal Clear Aligners, and other unique product offerings available from Clinician’s Choice, Sheer White, and Sprig Oral Health Technologies.

Recent Developments Within Dental Arm

Henry Schein’s strategy of expanding digital dentistry on a global basis is encouraging. It is busy promoting digital workflows for general dentistry and dental specialties. The company is currently focusing on offering a diversified portfolio and value-added services within the dental space.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lately, it has been investing in acquisitions that should strengthen its international presence in the dental implant space.

In August, the company announced the acquisition of Cliniclands that offers dental consumables, implants, prosthetic, and orthodontic solutions and equipment to dentists in Sweden, Denmark, and Norway. In July 2019, Henry Schein announced its foray into the Italian dental practice management software market with the small but crucial acquisition of Elite Computer Italia. In June 2019, it acquired Hayes Handpiece franchise, a leading provider of dental handpiece products and services in the United States, Canada, and the United Kingdom.

Price Performance

In the past six months, the stock has rallied 3.4% against the industry’s 8.8% decline.

Zacks Rank and Stocks Worth a Look

Henry Schein currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Haemonetics Corporation (NYSE:HAE) , NuVasive, Inc. (NASDAQ:NUVA) and ResMed (NYSE:RMD) . While Haemonetics carries a Zacks Rank #1 (Strong Buy), the other two carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Haemonetics has a projected long-term earnings growth rate of 13.5%.

NuVasive has an expected long-term earnings growth rate of 10.9%.

ResMed has a long-term earnings growth rate of 12.9%.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

See their latest picks free >>



Haemonetics Corporation (HAE): Free Stock Analysis Report

ResMed Inc. (RMD): Free Stock Analysis Report

NuVasive, Inc. (NUVA): Free Stock Analysis Report

Henry Schein, Inc. (HSIC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.